Motley Fool |
Tandem Diabetes Takes Aim at Medtronic's Artificial Pancreas
Motley Fool Insulin pump maker Tandem Diabetes Care (NASDAQ:TNDM) has secured an FDA OK that puts it on track to challenge Medtronic (NYSE:MDT) for the lead in the emerging market for closed-loop insulin systems. Is Tandem Diabetes stock a buy? |
from diabetes - Google News
Social Plugin